InvaGen launching Warfarin Sodium Tablets…

InvaGen Pharmaceuticals launching FDA approved Warfarin Sodium Tablets, USP 1 mg, 2 mg, 2.5 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7.5 mg and 10 mg.

Warfarin sodium tablets are indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism.

 

Warfarin sodium tablets are indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement.

 

Warfarin sodium tablets are indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

InvaGen Pharmaceuticals inaugurated its new facility…

InvaGen Pharmaceuticals inaugurated its new facility at 600 Old Willits Path in Hauppauge, NY